Q4 2024 Earnings Call Transcript February 4, 2025 Merck & Co., Inc. misses on earnings expectations. Reported EPS is $1.72 ...

Welcome to the Merck & Company Q4 sales and earnings conference call. [Operator instructions] This call is being recorded.

IDEXX Laboratories Inc (NASDAQ:IDXX) reported fourth-quarter adjusted EPS of $2.53, up 10% year-over-year, beating the ...

Dalan Animal Health, a pioneering biotechnology company developing vaccines that leverage innate immunity, announced today the appointment of Erin Strait, DVM, Ph.D., as Chief Scientific Officer (CSO) ...

Strait joins Dalan from Ceva Animal Health, where she served as Director of Innovation and Development for U.S. Poultry and Swine ... U.S. Swine Biologics at Merck Animal Health, accumulating ...

“Those are the US Merck or MSD and Boehringer Ingelheim ... especially in the more consolidated business units in animal health, such as poultry and swine.” “One day we can talk to an ...

The livestock monitoring market is expected to reach USD 2.57 billion by 2031 from USD 1.65 billion in 2025 at a CAGR of 7.7%, from 2025 to 2031 ...

The livestock identification market was valued at USD 1.74 billion in 2025 and is projected to reach USD 2.78 billion by 2031; it is expected ...

The 2025 Summit would not be possible without the support of sponsors, including U.S. Poultry & Egg Association, Cargill, Farm Journal, Meatingplace, Merck Animal Health, Watt Global Media, Zoetis, ...

Merck, the giant pharmaceutical company with multiple facilities in eastern Pennsylvania and New Jersey, isn’t too enthused ...

She pointed to the financial stake in litigation against the vaccine maker Merck — and his intention to hold on to it even if he gains regulatory power over the company as health secretary.